open access
Nongenomic effects of glucocorticoids
open access
Abstract
Abstract
Keywords
glucocorticoids; nongenomic and genomic action


Title
Nongenomic effects of glucocorticoids
Journal
Advances in Respiratory Medicine
Issue
Article type
Review paper
Pages
387-393
Published online
2009-06-26
Bibliographic record
Pneumonol Alergol Pol 2009;77(4):387-393.
Keywords
glucocorticoids
nongenomic and genomic action
Authors
Alicja Grzanka
Jerzy Jarząb


- Bartholome B, Spies CM, Gaber T, et al. Membrane glucocorticoid receptors (mGCR) are expressed in normal human peripheral blood mononuclear cells and up-regulated after in vitro stimulation and in patients with rheumatoid arthritis. FASEB J. 2004; 18(1): 70–80.
- Barnes PJ. How corticosteroids control inflammation: Quintiles Prize Lecture 2005. Br J Pharmacol. 2006; 148(3): 245–254.
- Mróz RM, Norparlik J, Chyczewska E, et al. Sygnalizacja zależna od histonów w farmakoterapii przewlekłej obturacyjnej choroby płuc. Pneumonol Alergol Pol. 2007; 75: 375–382.
- Stellato C. Post-transcriptional and Nongenomic Effects of Glucocorticoids. Proceedings of the American Thoracic Society. 2004; 1(3): 255–263.
- Selye H. Correlation between the chemical structure and the pharmacological actions of the steroids. Endocrinology. 1942; 30: 437–453.
- Löwenberg M, Stahn C, Hommes DW, et al. Novel insights into mechanisms of glucocorticoid action and the development of new glucocorticoid receptor ligands. Steroids. 2008; 73(9-10): 1025–1029.
- Liu L, Wang YX, Zhou J, et al. Rapid non-genomic inhibitory effects of glucocorticoids on human neutrophil degranulation. Inflamm Res. 2005; 54(1): 37–41.
- Urbach V, Walsh DE, Mainprice B, et al. Rapid non-genomic inhibition of ATP-induced Cl- secretion by dexamethasone in human bronchial epithelium. J Physiol. 2002; 545(Pt 3): 869–878.
- Park YS, Ha Choi Y, Park CH, et al. Nongenomic glucocorticoid effects on activity-dependent potentiation of catecholamine release in chromaffin cells. Endocrinology. 2008; 149(10): 4921–4927.
- Buttgereit F, Scheffold A. Rapid glucocorticoid effects on immune cells. Steroids. 2002; 67(6): 529–534.
- Hafezi-Moghadam A, Simoncini T, Yang Z, et al. Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase. Nat Med. 2002; 8(5): 473–479.
- Limbourg FP, Huang Z, Plumier JC, et al. Rapid nontranscriptional activation of endothelial nitric oxide synthase mediates increased cerebral blood flow and stroke protection by corticosteroids. J Clin Invest. 2002; 110(11): 1729–1738.
- Malcher-Lopes R, Di S, Marcheselli VS, et al. Opposing crosstalk between leptin and glucocorticoids rapidly modulates synaptic excitation via endocannabinoid release. J Neurosci. 2006; 26(24): 6643–6650.
- Tasker JG, Di S, Malcher-Lopes R. Minireview: rapid glucocorticoid signaling via membrane-associated receptors. Endocrinology. 2006; 147(12): 5549–5556.
- Croxtall JD, Choudhury Q, Flower RJ. Glucocorticoids act within minutes to inhibit recruitment of signalling factors to activated EGF receptors through a receptor-dependent, transcription-independent mechanism. Br J Pharmacol. 2000; 130(2): 289–298.
- Buttgereit F, da Silva JAP, Boers M, et al. Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology. Ann Rheum Dis. 2002; 61(8): 718–722.
- Haller J, Mikics E, Makara GB. The effects of non-genomic glucocorticoid mechanisms on bodily functions and the central neural system. A critical evaluation of findings. Front Neuroendocrinol. 2008; 29(2): 273–291.
- Reichardt HM, Kaestner KH, Tuckermann J, et al. DNA binding of the glucocorticoid receptor is not essential for survival. Cell. 1998; 93(4): 531–541.
- Farach-Carson MC, Davis PJ. Steroid hormone interactions with target cells: cross talk between membrane and nuclear pathways. J Pharmacol Exp Ther. 2003; 307(3): 839–845.